What should be monitored in a patient with acute coronary syndrome?

What should be monitored in a patient with acute coronary syndrome?

• A. Vital signs, serial ECG, troponin levels
• B. Lipid panel, sleep quality, and hair growth
• C. Only blood pressure
• D. Liver enzymes and bilirubin

Answer: (A)

During acute coronary syndrome, the priority is to continuously monitor signs of hemodynamic compromise and ongoing myocardial injury. Vital signs provide a quick read on stability—blood pressure, heart rate, respiratory rate, oxygen saturation, and mental status can reveal shock, tachyarrhythmias, bradyarrhythmias, or hypoxia that requires immediate intervention. Serial ECGs are essential because ACS can evolve over time. Repeating the ECGs helps detect new or changing ischemic changes, arrhythmias, or other acute electrical disturbances that would alter management, including the need for reperfusion or antiarrhythmic measures. Cardiac troponin levels indicate myocardial injury from ischemia. Serial measurements over several hours capture the rise and fall pattern typical of an acute infarct and are crucial for confirming the diagnosis, risk stratification, and guiding treatment decisions such as reperfusion therapy and antithrombotic strategies. Other data like lipid panels, sleep quality, or hair growth do not reflect the acute myocardial status, and focusing on blood pressure alone misses the broader picture of ischemia and injury. Liver enzymes and bilirubin likewise do not inform the current cardiac injury or risk in this setting.

During acute coronary syndrome, the priority is to continuously monitor signs of hemodynamic compromise and ongoing myocardial injury. Vital signs provide a quick read on stability—blood pressure, heart rate, respiratory rate, oxygen saturation, and mental status can reveal shock, tachyarrhythmias, bradyarrhythmias, or hypoxia that requires immediate intervention.

Serial ECGs are essential because ACS can evolve over time. Repeating the ECGs helps detect new or changing ischemic changes, arrhythmias, or other acute electrical disturbances that would alter management, including the need for reperfusion or antiarrhythmic measures.

Cardiac troponin levels indicate myocardial injury from ischemia. Serial measurements over several hours capture the rise and fall pattern typical of an acute infarct and are crucial for confirming the diagnosis, risk stratification, and guiding treatment decisions such as reperfusion therapy and antithrombotic strategies.

Other data like lipid panels, sleep quality, or hair growth do not reflect the acute myocardial status, and focusing on blood pressure alone misses the broader picture of ischemia and injury. Liver enzymes and bilirubin likewise do not inform the current cardiac injury or risk in this setting.